_id
6915fc00bc934aba376b2766
Ticker
SNPHY
Name
Santen Pharmaceutical Co
Exchange
PINK
Address
Grand Front Osaka Tower A, Osaka, Japan, 530-8552
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD
Website
https://www.santen.com/en
Description
Santen Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. Its product portfolio includes tafluprost/timolol maleate, a prostaglandin F2a derivative and a beta-adrenergic receptor blocker for the treatment of glaucoma and ocular hypertension; ciclosporin, an ophthalmic emulsion for the treatment of vernal keratoconjunctivitis, as well as latanoprost, an ophthalmic emulsion of a prostaglandin F2a derivative filed for marketing approval for the treatment of glaucoma and ocular hypertension; and epinastine hydrochloride, a histamine H1 receptor antagonist filed for marketing approval to treat allergic conjunctivitis. The company also offers netarsudil mesylate/latanoprost, a fixed dose combination drug of a ROCK inhibitor and a prostaglandin F2a derivative which is in phase III clinical trial for the treatment of glaucoma and ocular hypertension; and sepetaprost, a prostaglandin analogue eye drop drug that is in phase III clinical trials for the treatment of glaucoma and ocular hypertension. In addition, it develops oxymetazoline hydrochloride, a direct-acting alpha adrenergic receptor agonist which is in phase III clinical trial for treatment of ptosis; and omidenepag isopropyl, an EP2 receptor agonist that is in phase III clinical trial for the treatment of glaucoma and ocular hypertension. Further, the company offers atropine sulfate, a non-selective muscarinic antagonist that is in phase II/III clinical trials for the treatment of juvenile myopia; olodaterol hydrochloride, a ß2 receptor agonist that has completed phase 1/2a clinical trial for the treatment of a dry eye; and sirolimus, an ophthalmic suspension which is in phase 2a clinical trial for the treatment of fuchs endothelial corneal dystrophy and meibomian gland dysfunction. The company was founded in 1890 and is headquartered in Osaka, Japan.
Last Close
10
Volume
600
Current Price
11.15
Change
-0.01
Last Updated
2026-01-07T12:05:54.719Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3393644288
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.671
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
468848660
Cost Of Revenue
212447261
Gross Profit
256401399
Operating Expenses
186313468
Operating Income
70087931
Interest Expense
2814095
Pretax Income
69057226
Net Income
54668044
Eps
0.1607117902646386
Dividends Per Share
302037
Shares Outstanding
321672432
Income Tax Expense
14870630
EBITDA
103680777
Operating Margin
14.948945572330313
Total Other Income Expense Net
-1030704
Cash
63560000000
Short Term Investments
2524000000
Receivables
62691000000
Inventories
59282000000
Total Current Assets
195148000000
Property Plant Equipment
74812000000
Total Assets
389137000000
Payables
30612000000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
115530000000
Equity
274767000000
Bs_currency_symbol
JPY
Depreciation
31809451
Change In Working Capital
-57006808
Cash From Operations
40111051
Capital Expenditures
10503721
Cash From Investing
-50796107
Cash From Financing
-141670663
Net Change In Cash
-155162286
Cf_currency_symbol
-
PE
17.8814
PB
0.013803718423245877
ROE
0.019896146189316767
ROA
0.0140485340638387
FCF
29607330
Fcf Percent
0.06314901273259478
Piotroski FScore
3
Health Score
54
Deep Value Investing Score
9
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
8.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
9
Net Net Investing Score
9.5
Quality Investing Score
7
Value Investing Score
8.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
468848660
Quarters > 0 > income Statement > cost Of Revenue
212447261
Quarters > 0 > income Statement > gross Profit
256401399
Quarters > 0 > income Statement > operating Expenses
186313468
Quarters > 0 > income Statement > operating Income
70087931
Quarters > 0 > income Statement > interest Expense
2814095
Quarters > 0 > income Statement > pretax Income
69057226
Quarters > 0 > income Statement > net Income
54668044
Quarters > 0 > income Statement > eps
0.1607117902646386
Quarters > 0 > income Statement > dividends Per Share
302037
Quarters > 0 > income Statement > shares Outstanding
340162000
Quarters > 0 > income Statement > income Tax Expense
14870630
Quarters > 0 > income Statement > EBITDA
103680777
Quarters > 0 > income Statement > operating Margin
14.948945572330313
Quarters > 0 > income Statement > total Other Income Expense Net
-1030704
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
63560000000
Quarters > 0 > balance Sheet > short Term Investments
2524000000
Quarters > 0 > balance Sheet > receivables
62691000000
Quarters > 0 > balance Sheet > inventories
59282000000
Quarters > 0 > balance Sheet > total Current Assets
195148000000
Quarters > 0 > balance Sheet > property Plant Equipment
74812000000
Quarters > 0 > balance Sheet > total Assets
389137000000
Quarters > 0 > balance Sheet > payables
30612000000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
115530000000
Quarters > 0 > balance Sheet > equity
274767000000
Quarters > 0 > balance Sheet > currency_symbol
JPY
Quarters > 0 > cash Flow > net Income
54668044
Quarters > 0 > cash Flow > depreciation
31809451
Quarters > 0 > cash Flow > change In Working Capital
-57006808
Quarters > 0 > cash Flow > cash From Operations
40111051
Quarters > 0 > cash Flow > capital Expenditures
10503721
Quarters > 0 > cash Flow > cash From Investing
-50796107
Quarters > 0 > cash Flow > cash From Financing
-141670663
Quarters > 0 > cash Flow > net Change In Cash
-155162286
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.1607117902646386
Quarters > 0 > ratios > PB
0.013803718423245877
Quarters > 0 > ratios > ROE
0.019896146189316767
Quarters > 0 > ratios > ROA
0.0140485340638387
Quarters > 0 > ratios > FCF
29607330
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.06314901273259478
Quarters > 0 > health Score
54
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
68737000000
Quarters > 1 > income Statement > cost Of Revenue
31619000000
Quarters > 1 > income Statement > gross Profit
37118000000
Quarters > 1 > income Statement > operating Expenses
29545000000
Quarters > 1 > income Statement > operating Income
7573000000
Quarters > 1 > income Statement > interest Expense
122000000
Quarters > 1 > income Statement > pretax Income
7450000000
Quarters > 1 > income Statement > net Income
5878000000
Quarters > 1 > income Statement > eps
17.28000188145648
Quarters > 1 > income Statement > dividends Per Share
6408000000
Quarters > 1 > income Statement > shares Outstanding
340162000
Quarters > 1 > income Statement > income Tax Expense
1587000000
Quarters > 1 > income Statement > EBITDA
12070000000
Quarters > 1 > income Statement > operating Margin
11.017356009136273
Quarters > 1 > income Statement > total Other Income Expense Net
-123000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
84578000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
67398000000
Quarters > 1 > balance Sheet > inventories
59247000000
Quarters > 1 > balance Sheet > total Current Assets
221418000000
Quarters > 1 > balance Sheet > property Plant Equipment
72715000000
Quarters > 1 > balance Sheet > total Assets
408123000000
Quarters > 1 > balance Sheet > payables
42361000000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
127909000000
Quarters > 1 > balance Sheet > equity
281265000000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
5878000000
Quarters > 1 > cash Flow > depreciation
4497000000
Quarters > 1 > cash Flow > change In Working Capital
-5189000000
Quarters > 1 > cash Flow > cash From Operations
53428927
Quarters > 1 > cash Flow > capital Expenditures
12845087
Quarters > 1 > cash Flow > cash From Investing
-15170493
Quarters > 1 > cash Flow > cash From Financing
-106179612
Quarters > 1 > cash Flow > net Change In Cash
-36349373
Quarters > 1 > cash Flow > currency_symbol
JPY
Quarters > 1 > ratios > PE
17.28000188145648
Quarters > 1 > ratios > PB
0.013484814321013991
Quarters > 1 > ratios > ROE
2.0898440972037045
Quarters > 1 > ratios > ROA
1.4402520808677777
Quarters > 1 > ratios > FCF
40583840
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.0005904220434409416
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
77231000000
Quarters > 2 > income Statement > cost Of Revenue
31135000000
Quarters > 2 > income Statement > gross Profit
46096000000
Quarters > 2 > income Statement > operating Expenses
36233000000
Quarters > 2 > income Statement > operating Income
9863000000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
12172000000
Quarters > 2 > income Statement > net Income
8791000000
Quarters > 2 > income Statement > eps
25.752569105119463
Quarters > 2 > income Statement > dividends Per Share
67000000
Quarters > 2 > income Statement > shares Outstanding
341364000
Quarters > 2 > income Statement > income Tax Expense
3667000000
Quarters > 2 > income Statement > EBITDA
18485000000
Quarters > 2 > income Statement > operating Margin
12.770778573370798
Quarters > 2 > income Statement > total Other Income Expense Net
2309000000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
92997000000
Quarters > 2 > balance Sheet > short Term Investments
997000000
Quarters > 2 > balance Sheet > receivables
71759000000
Quarters > 2 > balance Sheet > inventories
51590000000
Quarters > 2 > balance Sheet > total Current Assets
224300000000
Quarters > 2 > balance Sheet > property Plant Equipment
72954000000
Quarters > 2 > balance Sheet > total Assets
409277000000
Quarters > 2 > balance Sheet > payables
38989000000
Quarters > 2 > balance Sheet > short Term Debt
3289000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
124096000000
Quarters > 2 > balance Sheet > equity
286242000000
Quarters > 2 > balance Sheet > currency_symbol
JPY
Quarters > 2 > cash Flow > net Income
8791000000
Quarters > 2 > cash Flow > depreciation
4399000000
Quarters > 2 > cash Flow > change In Working Capital
-18661000000
Quarters > 2 > cash Flow > cash From Operations
18890000000
Quarters > 2 > cash Flow > capital Expenditures
927000000
Quarters > 2 > cash Flow > cash From Investing
-976000000
Quarters > 2 > cash Flow > cash From Financing
-861000000
Quarters > 2 > cash Flow > net Change In Cash
92997000000
Quarters > 2 > cash Flow > currency_symbol
JPY
Quarters > 2 > ratios > PE
25.752569105119463
Quarters > 2 > ratios > PB
0.013297170226591486
Quarters > 2 > ratios > ROE
3.071177535092684
Quarters > 2 > ratios > ROA
2.147934039782348
Quarters > 2 > ratios > FCF
17963000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.23258795043441105
Quarters > 2 > health Score
65
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
76369000000
Quarters > 3 > income Statement > cost Of Revenue
34135000000
Quarters > 3 > income Statement > gross Profit
42234000000
Quarters > 3 > income Statement > operating Expenses
30451000000
Quarters > 3 > income Statement > operating Income
11783000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
11470000000
Quarters > 3 > income Statement > net Income
8693000000
Quarters > 3 > income Statement > eps
25.2157391695311
Quarters > 3 > income Statement > dividends Per Share
5876000000
Quarters > 3 > income Statement > shares Outstanding
344745000
Quarters > 3 > income Statement > income Tax Expense
2826000000
Quarters > 3 > income Statement > EBITDA
15830000000
Quarters > 3 > income Statement > operating Margin
15.429035341565294
Quarters > 3 > income Statement > total Other Income Expense Net
-313000000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
77851000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
69066000000
Quarters > 3 > balance Sheet > inventories
49998000000
Quarters > 3 > balance Sheet > total Current Assets
205138000000
Quarters > 3 > balance Sheet > property Plant Equipment
74387000000
Quarters > 3 > balance Sheet > total Assets
398307000000
Quarters > 3 > balance Sheet > payables
35791000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
115096000000
Quarters > 3 > balance Sheet > equity
284028000000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
8693000000
Quarters > 3 > cash Flow > depreciation
4507000000
Quarters > 3 > cash Flow > change In Working Capital
14652000000
Quarters > 3 > cash Flow > cash From Operations
13730000000
Quarters > 3 > cash Flow > capital Expenditures
3056000000
Quarters > 3 > cash Flow > cash From Investing
-2769000000
Quarters > 3 > cash Flow > cash From Financing
-20217000000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
JPY
Quarters > 3 > ratios > PE
25.2157391695311
Quarters > 3 > ratios > PB
0.013533548629008407
Quarters > 3 > ratios > ROE
3.0606137423070967
Quarters > 3 > ratios > ROA
2.1824873778266514
Quarters > 3 > ratios > FCF
10674000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.13976875433749297
Quarters > 3 > health Score
59
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
300004000000
Annuals > 0 > income Statement > cost Of Revenue
128977000000
Annuals > 0 > income Statement > gross Profit
171027000000
Annuals > 0 > income Statement > operating Expenses
124147000000
Annuals > 0 > income Statement > operating Income
46880000000
Annuals > 0 > income Statement > interest Expense
2716000000
Annuals > 0 > income Statement > pretax Income
47481000000
Annuals > 0 > income Statement > net Income
36256000000
Annuals > 0 > income Statement > eps
103.67921668658884
Annuals > 0 > income Statement > dividends Per Share
12111000000
Annuals > 0 > income Statement > shares Outstanding
349694000
Annuals > 0 > income Statement > income Tax Expense
11628000000
Annuals > 0 > income Statement > EBITDA
59009000000
Annuals > 0 > income Statement > operating Margin
15.626458313889149
Annuals > 0 > income Statement > total Other Income Expense Net
601000000
Annuals > 0 > income Statement > currency_symbol
JPY
Annuals > 0 > balance Sheet > cash
92997000000
Annuals > 0 > balance Sheet > short Term Investments
997000000
Annuals > 0 > balance Sheet > receivables
71759000000
Annuals > 0 > balance Sheet > inventories
51590000000
Annuals > 0 > balance Sheet > total Current Assets
224300000000
Annuals > 0 > balance Sheet > property Plant Equipment
72954000000
Annuals > 0 > balance Sheet > total Assets
409277000000
Annuals > 0 > balance Sheet > payables
38989000000
Annuals > 0 > balance Sheet > short Term Debt
3289000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
124096000000
Annuals > 0 > balance Sheet > equity
286242000000
Annuals > 0 > balance Sheet > currency_symbol
JPY
Annuals > 0 > cash Flow > net Income
36256000000
Annuals > 0 > cash Flow > depreciation
17948000000
Annuals > 0 > cash Flow > change In Working Capital
10209000000
Annuals > 0 > cash Flow > cash From Operations
60928000000
Annuals > 0 > cash Flow > capital Expenditures
6662000000
Annuals > 0 > cash Flow > cash From Investing
-8223000000
Annuals > 0 > cash Flow > cash From Financing
-53307000000
Annuals > 0 > cash Flow > net Change In Cash
92997000000
Annuals > 0 > cash Flow > currency_symbol
JPY
Annuals > 0 > ratios > PE
103.67921668658884
Annuals > 0 > ratios > PB
0.01288864562153702
Annuals > 0 > ratios > ROE
12.6662055184075
Annuals > 0 > ratios > ROA
8.85854812266509
Annuals > 0 > ratios > FCF
54266000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.18088425487660165
Annuals > 0 > health Score
71
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
301965000000
Annuals > 1 > income Statement > cost Of Revenue
123256000000
Annuals > 1 > income Statement > gross Profit
178709000000
Annuals > 1 > income Statement > operating Expenses
140168000000
Annuals > 1 > income Statement > operating Income
38541000000
Annuals > 1 > income Statement > interest Expense
2664000000
Annuals > 1 > income Statement > pretax Income
29874000000
Annuals > 1 > income Statement > net Income
26642000000
Annuals > 1 > income Statement > eps
72.36999369798119
Annuals > 1 > income Statement > dividends Per Share
11881000000
Annuals > 1 > income Statement > shares Outstanding
368136000
Annuals > 1 > income Statement > income Tax Expense
3171000000
Annuals > 1 > income Statement > EBITDA
50716000000
Annuals > 1 > income Statement > operating Margin
12.76339973175699
Annuals > 1 > income Statement > total Other Income Expense Net
-8667000000
Annuals > 1 > income Statement > currency_symbol
JPY
Annuals > 1 > balance Sheet > cash
94582000000
Annuals > 1 > balance Sheet > short Term Investments
379000000
Annuals > 1 > balance Sheet > receivables
90539000000
Annuals > 1 > balance Sheet > inventories
43185000000
Annuals > 1 > balance Sheet > total Current Assets
236139000000
Annuals > 1 > balance Sheet > property Plant Equipment
71576000000
Annuals > 1 > balance Sheet > total Assets
435699000000
Annuals > 1 > balance Sheet > payables
43531000000
Annuals > 1 > balance Sheet > short Term Debt
2748000000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
130330000000
Annuals > 1 > balance Sheet > equity
306055000000
Annuals > 1 > balance Sheet > currency_symbol
JPY
Annuals > 1 > cash Flow > net Income
26642000000
Annuals > 1 > cash Flow > depreciation
18178000000
Annuals > 1 > cash Flow > change In Working Capital
14168000000
Annuals > 1 > cash Flow > cash From Operations
72649000000
Annuals > 1 > cash Flow > capital Expenditures
10687000000
Annuals > 1 > cash Flow > cash From Investing
-6145000000
Annuals > 1 > cash Flow > cash From Financing
-34031000000
Annuals > 1 > cash Flow > net Change In Cash
36679000000
Annuals > 1 > cash Flow > currency_symbol
JPY
Annuals > 1 > ratios > PE
72.36999369798119
Annuals > 1 > ratios > PB
0.012689989707732273
Annuals > 1 > ratios > ROE
8.704971328682753
Annuals > 1 > ratios > ROA
6.114771895276326
Annuals > 1 > ratios > FCF
61962000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.20519596641994933
Annuals > 1 > health Score
71
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
279037000000
Annuals > 2 > income Statement > cost Of Revenue
112950000000
Annuals > 2 > income Statement > gross Profit
166087000000
Annuals > 2 > income Statement > operating Expenses
169177000000
Annuals > 2 > income Statement > operating Income
-3090000000
Annuals > 2 > income Statement > interest Expense
1499000000
Annuals > 2 > income Statement > pretax Income
-5799000000
Annuals > 2 > income Statement > net Income
-14948000000
Annuals > 2 > income Statement > eps
-38.583449486345565
Annuals > 2 > income Statement > dividends Per Share
12607000000
Annuals > 2 > income Statement > shares Outstanding
387420000
Annuals > 2 > income Statement > income Tax Expense
9184000000
Annuals > 2 > income Statement > EBITDA
12949000000
Annuals > 2 > income Statement > operating Margin
-1.1073800248712538
Annuals > 2 > income Statement > total Other Income Expense Net
-2709000000
Annuals > 2 > income Statement > currency_symbol
JPY
Annuals > 2 > balance Sheet > cash
57903000000
Annuals > 2 > balance Sheet > short Term Investments
774000000
Annuals > 2 > balance Sheet > receivables
107165000000
Annuals > 2 > balance Sheet > inventories
39352000000
Annuals > 2 > balance Sheet > total Current Assets
213326000000
Annuals > 2 > balance Sheet > property Plant Equipment
66173000000
Annuals > 2 > balance Sheet > total Assets
421179000000
Annuals > 2 > balance Sheet > payables
44945000000
Annuals > 2 > balance Sheet > short Term Debt
3056000000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
127882000000
Annuals > 2 > balance Sheet > equity
293979000000
Annuals > 2 > balance Sheet > currency_symbol
JPY
Annuals > 2 > cash Flow > net Income
-14983000000
Annuals > 2 > cash Flow > depreciation
17249000000
Annuals > 2 > cash Flow > change In Working Capital
-5059000000
Annuals > 2 > cash Flow > cash From Operations
37147000000
Annuals > 2 > cash Flow > capital Expenditures
24588000000
Annuals > 2 > cash Flow > cash From Investing
-26777000000
Annuals > 2 > cash Flow > cash From Financing
-37220000000
Annuals > 2 > cash Flow > net Change In Cash
-25111000000
Annuals > 2 > cash Flow > currency_symbol
JPY
Annuals > 2 > ratios > PE
-38.583449486345565
Annuals > 2 > ratios > PB
0.013903309420060619
Annuals > 2 > ratios > ROE
-5.084716935563425
Annuals > 2 > ratios > ROA
-3.5490848309151217
Annuals > 2 > ratios > FCF
12559000000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.045008368065883736
Annuals > 2 > health Score
37
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
266257000000
Annuals > 3 > income Statement > cost Of Revenue
109671000000
Annuals > 3 > income Statement > gross Profit
156586000000
Annuals > 3 > income Statement > operating Expenses
120700000000
Annuals > 3 > income Statement > operating Income
35886000000
Annuals > 3 > income Statement > interest Expense
1209000000
Annuals > 3 > income Statement > pretax Income
35616000000
Annuals > 3 > income Statement > net Income
27218000000
Annuals > 3 > income Statement > eps
67.96734730570323
Annuals > 3 > income Statement > dividends Per Share
11994000000
Annuals > 3 > income Statement > shares Outstanding
400457000
Annuals > 3 > income Statement > income Tax Expense
8427000000
Annuals > 3 > income Statement > EBITDA
52930000000
Annuals > 3 > income Statement > operating Margin
13.477955509150933
Annuals > 3 > income Statement > total Other Income Expense Net
-270000000
Annuals > 3 > income Statement > currency_symbol
JPY
Annuals > 3 > balance Sheet > cash
83014000000
Annuals > 3 > balance Sheet > short Term Investments
1293000000
Annuals > 3 > balance Sheet > receivables
99591000000
Annuals > 3 > balance Sheet > inventories
37141000000
Annuals > 3 > balance Sheet > total Current Assets
229426000000
Annuals > 3 > balance Sheet > property Plant Equipment
56287000000
Annuals > 3 > balance Sheet > total Assets
459976000000
Annuals > 3 > balance Sheet > payables
41185000000
Annuals > 3 > balance Sheet > short Term Debt
13965000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
123132000000
Annuals > 3 > balance Sheet > equity
337488000000
Annuals > 3 > balance Sheet > currency_symbol
JPY
Annuals > 3 > cash Flow > net Income
27189000000
Annuals > 3 > cash Flow > depreciation
17055000000
Annuals > 3 > cash Flow > change In Working Capital
4706000000
Annuals > 3 > cash Flow > cash From Operations
46043000000
Annuals > 3 > cash Flow > capital Expenditures
35841000000
Annuals > 3 > cash Flow > cash From Investing
-35169000000
Annuals > 3 > cash Flow > cash From Financing
5557000000
Annuals > 3 > cash Flow > net Change In Cash
20126000000
Annuals > 3 > cash Flow > currency_symbol
JPY
Annuals > 3 > ratios > PE
67.96734730570323
Annuals > 3 > ratios > PB
0.012518434285070877
Annuals > 3 > ratios > ROE
8.064879343858152
Annuals > 3 > ratios > ROA
5.917265248621667
Annuals > 3 > ratios > FCF
10202000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.038316363513447534
Annuals > 3 > health Score
54
Valuation > metrics > PE
17.8814
Valuation > metrics > PB
0.013803718423245877
Valuation > final Score
100
Valuation > verdict
49.3% Undervalued
Profitability > metrics > ROE
0.019896146189316767
Profitability > metrics > ROA
0.02801363273003054
Profitability > metrics > Net Margin
0.1166006190569042
Profitability > final Score
18
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4204653397242027
Risk > metrics > Interest Coverage
24.906028758801675
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
6.374885665751993
Liquidity > metrics > Quick Ratio
4.4383248399320525
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
69.09691707385664
Prev Valuations > 2
69.74111299656268
Prev Profitabilities > 0
25
Prev Profitabilities > 1
35
Prev Profitabilities > 2
36
Prev Risks > 0
100
Prev Risks > 1
66
Prev Risks > 2
71
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:36:01.576Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-11
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-04
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-11-06
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
24.55
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
24.55
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-04
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.1196
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-13
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
25.69
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-06
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
JPY
Earnings History > 5 > eps Actual
0.1656
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-11-07
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
JPY
Earnings History > 6 > eps Actual
0.1557
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-08-06
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
JPY
Earnings History > 7 > eps Actual
0.1893
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-05-09
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
JPY
Earnings History > 8 > eps Actual
0.0006
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-02-08
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
JPY
Earnings History > 9 > eps Actual
0.1397
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-09-30
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
JPY
Earnings History > 10 > eps Actual
0.1696
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
JPY
Earnings History > 11 > eps Actual
0.2025
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
JPY
Earnings History > 12 > eps Actual
0.0224
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2022-12-31
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
JPY
Earnings History > 13 > eps Actual
0.1093
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-09-30
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
JPY
Earnings History > 14 > eps Actual
-0.5462
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-06-30
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
JPY
Earnings History > 15 > eps Actual
0.1292
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-03-31
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
JPY
Earnings History > 16 > eps Actual
0.169
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2021-12-31
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
JPY
Earnings History > 17 > eps Actual
0.1106
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-09-30
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
JPY
Earnings History > 18 > eps Actual
0.158
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-09-30
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
JPY
Earnings History > 19 > eps Actual
0.1563
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-06-30
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
JPY
Earnings History > 20 > eps Actual
0.1651
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2021-03-31
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
JPY
Earnings History > 21 > eps Actual
-0.3229
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-12-31
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
JPY
Earnings History > 22 > eps Actual
0.1766
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-08-04
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
JPY
Earnings History > 23 > eps Actual
15.49
Earnings History > 23 > eps Estimate
16.9
Earnings History > 23 > eps Difference
-1.41
Earnings History > 23 > surprise Percent
-8.3432
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-05-07
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
JPY
Earnings History > 24 > eps Actual
8.3
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2020-02-03
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
JPY
Earnings History > 25 > eps Actual
17.92
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-11-05
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
JPY
Earnings History > 26 > eps Actual
16.91
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-07-31
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
JPY
Earnings History > 27 > eps Actual
16.03
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-05-08
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
JPY
Earnings History > 28 > eps Actual
21.23
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-12-31
Earnings History > 29 > report Date
2019-02-04
Earnings History > 29 > date
2018-12-31
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
JPY
Earnings History > 29 > eps Actual
22.1
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-09-30
Earnings History > 30 > report Date
2018-11-06
Earnings History > 30 > date
2018-09-30
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
JPY
Earnings History > 30 > eps Actual
18.49
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-06-30
Earnings History > 31 > report Date
2018-07-31
Earnings History > 31 > date
2018-06-30
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
JPY
Earnings History > 31 > eps Actual
16.85
Earnings History > 31 > eps Estimate
22.6
Earnings History > 31 > eps Difference
-5.75
Earnings History > 31 > surprise Percent
-25.4425
Earnings History > 32 > period
2018-03-31
Earnings History > 32 > report Date
2018-05-08
Earnings History > 32 > date
2018-03-31
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
JPY
Earnings History > 32 > eps Actual
19.46
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-12-31
Earnings History > 33 > report Date
2018-02-05
Earnings History > 33 > date
2017-12-31
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
JPY
Earnings History > 33 > eps Actual
29.71
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-09-30
Earnings History > 34 > report Date
2017-11-01
Earnings History > 34 > date
2017-09-30
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
JPY
Earnings History > 34 > eps Actual
15.6
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-06-30
Earnings History > 35 > report Date
2017-07-31
Earnings History > 35 > date
2017-06-30
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
JPY
Earnings History > 35 > eps Actual
21.96
Earnings History > 35 > eps Estimate
19.7
Earnings History > 35 > eps Difference
2.26
Earnings History > 35 > surprise Percent
11.4721
Earnings History > 36 > period
2017-03-31
Earnings History > 36 > report Date
2017-05-09
Earnings History > 36 > date
2017-03-31
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
JPY
Earnings History > 36 > eps Actual
8
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-12-31
Earnings History > 37 > report Date
2017-02-06
Earnings History > 37 > date
2016-12-31
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
JPY
Earnings History > 37 > eps Actual
17.68
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-09-30
Earnings History > 38 > report Date
2016-11-01
Earnings History > 38 > date
2016-09-30
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
JPY
Earnings History > 38 > eps Actual
12.76
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-06-30
Earnings History > 39 > report Date
2016-08-01
Earnings History > 39 > date
2016-06-30
Earnings History > 39 > before After Market
AfterMarket
Earnings History > 39 > currency
JPY
Earnings History > 39 > eps Actual
17.68
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2016-03-31
Earnings History > 40 > report Date
2016-05-11
Earnings History > 40 > date
2016-03-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
JPY
Earnings History > 40 > eps Actual
8.42
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-12-31
Earnings History > 41 > report Date
2016-02-01
Earnings History > 41 > date
2015-12-31
Earnings History > 41 > before After Market
AfterMarket
Earnings History > 41 > currency
JPY
Earnings History > 41 > eps Actual
15.04
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-09-30
Earnings History > 42 > report Date
2015-11-03
Earnings History > 42 > date
2015-09-30
Earnings History > 42 > before After Market
AfterMarket
Earnings History > 42 > currency
JPY
Earnings History > 42 > eps Actual
87.31
Earnings History > 42 > eps Estimate
-
Earnings History > 42 > eps Difference
0
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2015-06-30
Earnings History > 43 > report Date
2015-08-04
Earnings History > 43 > date
2015-06-30
Earnings History > 43 > before After Market
BeforeMarket
Earnings History > 43 > currency
JPY
Earnings History > 43 > eps Actual
0.7258
Earnings History > 43 > eps Estimate
-
Earnings History > 43 > eps Difference
0
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2015-03-31
Earnings History > 44 > report Date
2015-05-12
Earnings History > 44 > date
2015-03-31
Earnings History > 44 > before After Market
AfterMarket
Earnings History > 44 > currency
JPY
Earnings History > 44 > eps Actual
18.98
Earnings History > 44 > eps Estimate
10.54
Earnings History > 44 > eps Difference
8.44
Earnings History > 44 > surprise Percent
80.0759
Earnings History > 45 > period
2014-12-31
Earnings History > 45 > report Date
2015-02-02
Earnings History > 45 > date
2014-12-31
Earnings History > 45 > before After Market
AfterMarket
Earnings History > 45 > currency
JPY
Earnings History > 45 > eps Actual
0.1574
Earnings History > 45 > eps Estimate
-
Earnings History > 45 > eps Difference
0
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2014-09-30
Earnings History > 46 > report Date
2014-11-04
Earnings History > 46 > date
2014-09-30
Earnings History > 46 > before After Market
AfterMarket
Earnings History > 46 > currency
JPY
Earnings History > 46 > eps Actual
0.1426
Earnings History > 46 > eps Estimate
-
Earnings History > 46 > eps Difference
0
Earnings History > 46 > surprise Percent
-
Earnings History > 47 > period
2014-06-30
Earnings History > 47 > report Date
2014-08-04
Earnings History > 47 > date
2014-06-30
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
JPY
Earnings History > 47 > eps Actual
9.04
Earnings History > 47 > eps Estimate
10.18
Earnings History > 47 > eps Difference
-1.14
Earnings History > 47 > surprise Percent
-11.1984
Earnings History > 48 > period
2014-03-31
Earnings History > 48 > report Date
2014-06-30
Earnings History > 48 > date
2014-03-31
Earnings History > 48 > before After Market
-
Earnings History > 48 > currency
JPY
Earnings History > 48 > eps Actual
0.0889
Earnings History > 48 > eps Estimate
-
Earnings History > 48 > eps Difference
0
Earnings History > 48 > surprise Percent
-
Earnings History > 49 > period
2013-12-31
Earnings History > 49 > report Date
2014-03-31
Earnings History > 49 > date
2013-12-31
Earnings History > 49 > before After Market
-
Earnings History > 49 > currency
JPY
Earnings History > 49 > eps Actual
0.0406
Earnings History > 49 > eps Estimate
-
Earnings History > 49 > eps Difference
0
Earnings History > 49 > surprise Percent
-
Earnings History > 50 > period
2013-09-30
Earnings History > 50 > report Date
2013-12-31
Earnings History > 50 > date
2013-09-30
Earnings History > 50 > before After Market
-
Earnings History > 50 > currency
JPY
Earnings History > 50 > eps Actual
0.1465
Earnings History > 50 > eps Estimate
-
Earnings History > 50 > eps Difference
0
Earnings History > 50 > surprise Percent
-
Earnings History > 51 > period
2013-06-30
Earnings History > 51 > report Date
2013-09-30
Earnings History > 51 > date
2013-06-30
Earnings History > 51 > before After Market
-
Earnings History > 51 > currency
JPY
Earnings History > 51 > eps Actual
0.0845
Earnings History > 51 > eps Estimate
-
Earnings History > 51 > eps Difference
0
Earnings History > 51 > surprise Percent
-
Earnings History > 52 > period
2013-03-31
Earnings History > 52 > report Date
2013-06-30
Earnings History > 52 > date
2013-03-31
Earnings History > 52 > before After Market
-
Earnings History > 52 > currency
JPY
Earnings History > 52 > eps Actual
0.1355
Earnings History > 52 > eps Estimate
-
Earnings History > 52 > eps Difference
0
Earnings History > 52 > surprise Percent
-
Earnings History > 53 > period
2012-12-31
Earnings History > 53 > report Date
2013-03-31
Earnings History > 53 > date
2012-12-31
Earnings History > 53 > before After Market
-
Earnings History > 53 > currency
JPY
Earnings History > 53 > eps Actual
0.0612
Earnings History > 53 > eps Estimate
-
Earnings History > 53 > eps Difference
0
Earnings History > 53 > surprise Percent
-
Earnings History > 54 > period
2012-09-30
Earnings History > 54 > report Date
2012-12-31
Earnings History > 54 > date
2012-09-30
Earnings History > 54 > before After Market
-
Earnings History > 54 > currency
JPY
Earnings History > 54 > eps Actual
0.1447
Earnings History > 54 > eps Estimate
-
Earnings History > 54 > eps Difference
0
Earnings History > 54 > surprise Percent
-
Earnings History > 55 > period
2012-06-30
Earnings History > 55 > report Date
2012-09-30
Earnings History > 55 > date
2012-06-30
Earnings History > 55 > before After Market
-
Earnings History > 55 > currency
JPY
Earnings History > 55 > eps Actual
0.1409
Earnings History > 55 > eps Estimate
-
Earnings History > 55 > eps Difference
0
Earnings History > 55 > surprise Percent
-
Earnings History > 56 > period
2012-03-31
Earnings History > 56 > report Date
2012-06-30
Earnings History > 56 > date
2012-03-31
Earnings History > 56 > before After Market
-
Earnings History > 56 > currency
JPY
Earnings History > 56 > eps Actual
0.1227
Earnings History > 56 > eps Estimate
-
Earnings History > 56 > eps Difference
0
Earnings History > 56 > surprise Percent
-
Earnings History > 57 > period
2011-12-31
Earnings History > 57 > report Date
2012-03-31
Earnings History > 57 > date
2011-12-31
Earnings History > 57 > before After Market
-
Earnings History > 57 > currency
JPY
Earnings History > 57 > eps Actual
0.0666
Earnings History > 57 > eps Estimate
-
Earnings History > 57 > eps Difference
0
Earnings History > 57 > surprise Percent
-
Earnings History > 58 > period
2011-09-30
Earnings History > 58 > report Date
2011-12-31
Earnings History > 58 > date
2011-09-30
Earnings History > 58 > before After Market
-
Earnings History > 58 > currency
JPY
Earnings History > 58 > eps Actual
0.1449
Earnings History > 58 > eps Estimate
-
Earnings History > 58 > eps Difference
0
Earnings History > 58 > surprise Percent
-
Earnings History > 59 > period
2011-06-30
Earnings History > 59 > report Date
2011-09-30
Earnings History > 59 > date
2011-06-30
Earnings History > 59 > before After Market
-
Earnings History > 59 > currency
JPY
Earnings History > 59 > eps Actual
0.1303
Earnings History > 59 > eps Estimate
0
Earnings History > 59 > eps Difference
0.1303
Earnings History > 59 > surprise Percent
-
Earnings History > 60 > period
2011-03-31
Earnings History > 60 > report Date
2011-06-30
Earnings History > 60 > date
2011-03-31
Earnings History > 60 > before After Market
-
Earnings History > 60 > currency
JPY
Earnings History > 60 > eps Actual
0.1571
Earnings History > 60 > eps Estimate
0
Earnings History > 60 > eps Difference
0.1571
Earnings History > 60 > surprise Percent
-
Earnings History > 61 > period
2010-12-31
Earnings History > 61 > report Date
2011-03-31
Earnings History > 61 > date
2010-12-31
Earnings History > 61 > before After Market
-
Earnings History > 61 > currency
JPY
Earnings History > 61 > eps Actual
0.1858
Earnings History > 61 > eps Estimate
0
Earnings History > 61 > eps Difference
0.1858
Earnings History > 61 > surprise Percent
-
Earnings History > 62 > period
2010-09-30
Earnings History > 62 > report Date
2010-12-31
Earnings History > 62 > date
2010-09-30
Earnings History > 62 > before After Market
-
Earnings History > 62 > currency
JPY
Earnings History > 62 > eps Actual
0.1564
Earnings History > 62 > eps Estimate
0
Earnings History > 62 > eps Difference
0.1564
Earnings History > 62 > surprise Percent
-
Santen Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. Its product portfolio includes tafluprost/timolol maleate, a prostaglandin F2a derivative and a beta-adrenergic receptor blocker for the treatment of glaucoma and ocular hypertension; ciclosporin, an ophthalmic emulsion for the treatment of vernal keratoconjunctivitis, as well as latanoprost, an ophthalmic emulsion of a prostaglandin F2a derivative filed for marketing approval for the treatment of glaucoma and ocular hypertension; and epinastine hydrochloride, a histamine H1 receptor antagonist filed for marketing approval to treat allergic conjunctivitis. The company also offers netarsudil mesylate/latanoprost, a fixed dose combination drug of a ROCK inhibitor and a prostaglandin F2a derivative which is in phase III clinical trial for the treatment of glaucoma and ocular hypertension; and sepetaprost, a prostaglandin analogue eye drop drug that is in phase III clinical trials for the treatment of glaucoma and ocular hypertension. In addition, it develops oxymetazoline hydrochloride, a direct-acting alpha adrenergic receptor agonist which is in phase III clinical trial for treatment of ptosis; and omidenepag isopropyl, an EP2 receptor agonist that is in phase III clinical trial for the treatment of glaucoma and ocular hypertension. Further, the company offers atropine sulfate, a non-selective muscarinic antagonist that is in phase II/III clinical trials for the treatment of juvenile myopia; olodaterol hydrochloride, a ß2 receptor agonist that has completed phase 1/2a clinical trial for the treatment of a dry eye; and sirolimus, an ophthalmic suspension which is in phase 2a clinical trial for the treatment of fuchs endothelial corneal dystrophy and meibomian gland dysfunction. The company was founded in 1890 and is headquartered in Osaka, Japan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Santen Pharmaceutical Co
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
24.55
EPS Estimate
0
EPS Difference
24.55
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.